DoD Gulf War Illness, Idea Award | W81XWH 19 GWIRP IA

Opportunity Information: Apply for W81XWH 19 GWIRP IA

The DoD Gulf War Illness (GWI) Idea Award (FY19 GWIRP IA; Funding Opportunity Number W81XWH 19 GWIRP IA) is a Department of Defense research funding opportunity run through the U.S. Army Medical Research Acquisition Activity (USAMRAA). It supports science and technology research intended to improve the health of Veterans affected by Gulf War Illness, specifically those who served in the 1990-1991 Gulf War. Awards may be made as grants or cooperative agreements under CFDA 12.420, and eligibility is described as unrestricted, meaning a wide range of organizations can apply unless additional eligibility notes in the full announcement say otherwise. The opportunity was posted May 16, 2019, with an original closing date of October 3, 2019, and it anticipated making about three awards. The listing shows an award ceiling of 0, which typically indicates the ceiling was not specified in the summary record and applicants would need to consult the full solicitation for budget limits and project period details.

A central requirement of this Idea Award is a clear, explicit focus on Gulf War Illness itself, not just on related biology in a general or indirect way. The program places strong emphasis on impact: every application must explain how the proposed work could lead to clinical impact for Veterans with GWI, even if the study is not a clinical trial and even if immediate clinical outcomes are not expected within the project timeline. In other words, applicants need to draw a credible line from the proposed research to potential improvements in diagnosis, prognosis, stratification of patients, treatment development, or other practical outcomes that matter for Veterans living with GWI. The burden is on the Principal Investigator to articulate that pathway to impact plainly and convincingly.

The announcement also highlights a set of FY19 “topics of special interest,” which function as priority areas the program is especially interested in funding. While applicants are not limited to these topics and can propose other GWI-relevant research aligned with the program’s mission and overarching challenges, the solicitation makes it clear that studying mechanisms outside the context of GWI is not within scope. That means the work should be anchored in Gulf War Illness features, GWI patient data, GWI-relevant cohorts, or hypotheses explicitly tied to the illness as experienced by Gulf War Veterans.

Within the special interest topics, one emphasis area is the epidemiology of comorbidities and mortality in GWI, including analysis of gender or ethnic differences and the role of specific health abnormalities that may be part of the GWI picture. Examples specifically called out include sinus and respiratory issues, gastrointestinal problems, sleep abnormalities, and dermatological (skin) conditions. Another focus area is understanding how individual GWI symptoms interact with each other, including the role of non-refreshing sleep, and how symptom clusters (groups of symptoms that tend to occur together) relate to downstream health outcomes and overall well-being. This reflects an interest not only in single-symptom studies but also in the complex, multi-system nature of GWI and the ways different symptom patterns might correspond to different underlying biology or risk trajectories.

The solicitation also prioritizes research into genetic factors that may predispose certain individuals to developing GWI, suggesting interest in inherited susceptibility and gene-environment interactions that could help explain why some exposed Veterans developed persistent illness while others did not. Closely related is an interest in identifying molecular signatures or biomarkers underlying symptom clusters using modern “omics” approaches, including genomic, proteomic, metabolic, and epigenetic technologies. In practical terms, this points to studies that could help move the field toward measurable indicators of disease state, subtype, severity, or progression, potentially supporting better diagnostic tools and more targeted therapeutic development.

A major theme running through the topics is multi-organ system dysregulation and abnormal cross-talk between systems, including examples like neuroinflammation and autonomic dysfunction. The program places particular emphasis on the neurological system (central, peripheral, autonomic, and/or neuromuscular), the immune system, and endocrine/exocrine/excretory systems. Within these, the solicitation specifically calls attention to kidney and liver function, including possible Cytochrome P450 abnormalities, which are relevant because Cytochrome P450 enzymes influence metabolism of many chemicals and drugs and could plausibly intersect with toxicant exposure histories and variable susceptibility in Gulf War Veterans.

Methodologically, the opportunity encourages approaches that reflect the “current status” of GWI patients and the realities of long-term illness. It notes that measuring parameters at baseline and after a challenge (such as stress, exercise, or an immune challenge) should be considered, along with attention to long-term and latent effects of toxicant exposures. This signals interest in study designs that can reveal dysfunction that might not be obvious at rest, and in models that account for delayed or persistent biological changes tied to exposures that occurred decades ago.

Overall, the DoD GWI Idea Award is designed to stimulate innovative, GWI-specific research that can plausibly feed into real-world clinical benefit for affected Gulf War Veterans. Successful proposals, based on the summary, would be expected to stay tightly grounded in Gulf War Illness as a defined Veteran health problem, align with prioritized scientific questions about symptom clusters, susceptibility, biomarkers, and multi-system dysfunction, and clearly explain how the findings could translate into better clinical understanding or care, even if the study itself is not immediately clinical.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Gulf War Illness, Idea Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on May 16, 2019.
• Applicants must submit their applications by Oct 03, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 3 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 19 GWIRP IA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: